Zydus Lifesciences arm, MSN Labs collaborate to license, supply cancer drug Cabozantinib in US Ruchika Sharma18 May 2024 12:27 PM ISTAhmedabad: Zydus Lifesciences Ltd., a global innovation driven healthcare company has announced that its wholly owned subsidiary, Zydus...
Zydus Lifesciences Dexamethasone Tablets bags USFDA okay Ruchika Sharma13 May 2024 11:22 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...
Zydus Lifesciences completes enrolment for EPICS III Phase 2b/3 trial evaluating Saroglitazar Mg for Primary Biliary Cholangitis Ruchika Sharma10 May 2024 11:56 AM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
Zydus Lifesciences bags USFDA nod for Dapsone Gel for acne treatment Ruchika Sharma9 May 2024 2:52 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Dapsone...
Zydus Lifesciences bags USFDA nod for acne cream Tretinoin Ruchika Sharma27 April 2024 11:39 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...
USFDA issues 10 observations for Zydus Lifesciences Jarod facility Ruchika Sharma24 April 2024 4:01 PM ISTAhmedabad: Zydus Lifesciences has informed in a BSE filing that the US Food and Drug Administration (USFDA) has concluded an inspection with...
New Drug Application of Zydus Desidustat tablets by China Medical System Holdings accepted in China Ruchika Sharma24 April 2024 3:02 PM ISTDiscovered and developed by Zydus, Desidustat is being marketed by the group in India under the brand name Oxemia.
Zydus Lifesciences launches Mirabegron ER Tablets in US for overactive bladder treatment Ruchika Sharma22 April 2024 2:47 PM ISTMirabegron is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and urinary frequency.
Zydus Lifesciences arm gets marketing nod for Nulibry from UK MHRA for MoCD Type A Ruchika Sharma22 April 2024 2:08 PM ISTAhmedabad: Zydus Lifesciences Ltd. has announced that its wholly-owned subsidiary Sentynl Therapeutics, Inc., has received marketing...
Zydus Lifesciences gets WHO INN approval for 'Usnoflast' as recommended name for ZYIL1 Ruchika Sharma2 April 2024 1:30 PM ISTUsnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus.
USFDA inspection: Zydus Lifesciences gets 4 observations for Ahmedabad plant Ruchika Sharma28 March 2024 12:30 PM ISTAhmedabad: Zydus Lifesciences has announced that the Company has received four observations from the U.S. Food and Drug Administration (USFDA) at...
Zydus Lifesciences receives tentative approval from USFDA for Letermovir Tablets Ruchika Sharma24 March 2024 2:30 PM ISTLetermovir tablets are used to prevent disease caused by a virus called cytomegalovirus in people who have received a bone marrow transplant or kidney...
